Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica

Clinica Chimica Acta

Volumn 469, Issue , 2017, Pages 144-149

  Uzawa, Akiyuki ^a   Mori, Masahiro ^a   Masuda, Hiroki ^a   Ohtani, Ryohei ^a   Uchida, Tomohiko ^a   Sawai, Setsu ^a   Kuwabara, Satoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Biomarker; Cerebrospinal fluid; Cutoff; Interleukin 6; Neuromyelitis optica

Indexed keywords

AQUAPORIN 4 ANTIBODY; INTERLEUKIN 6; METHYLPREDNISOLONE; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; OPTIC NEURITIS; PLASMAPHERESIS; PROTEIN ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPINAL CORD LESION; UPREGULATION; CEREBROSPINAL FLUID; MIDDLE AGED; REFERENCE VALUE;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; REFERENCE VALUES;

EID: 85017560348     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2017.03.006     Document Type: Article

References (31)

1. [1] Kishimoto, T., Interleukin-6: from basic science to medicine—40 years in immunology. Annu. Rev. Immunol. 23 (2005), 1–21.
2. [2] Kimura, A., Kishimoto, T., IL-6: regulator of Treg/Th17 balance. Eur. J. Immunol. 40 (2010), 1830–1835.
3. [3] Weaver, C.T., Hatton, R.D., Mangan, P.R., Harrington, L.E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25 (2007), 821–852.
4. [4] Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441 (2006), 235–238.
5. [5] Wingerchuk, D.M., Banwell, B., Bennett, J.L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., Jarius, S., Lana-Peixoto, M., Levy, M., Simon, J.H., Tenembaum, S., Traboulsee, A.L., Waters, P., Wellik, K.E., Weinshenker, B.G., International Panel for NMO Diagnosis, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85 (2015), 177–189.
6. [6] Uzawa, A., Mori, M., Arai, K., Sato, Y., Hayakawa, S., Masuda, S., Taniguchi, J., Kuwabara, S., Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult. Scler. 16 (2010), 1443–1452.
7. [7] Uzawa, A., Mori, M., Sato, Y., Masuda, S., Kuwabara, S., CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse. J. Neurol. Neurosurg. Psychiatry 83 (2012), 339–340.
8. [8] Uzawa, A., Mori, M., Sawai, S., Masuda, S., Muto, M., Uchida, T., Ito, S., Nomura, F., Kuwabara, S., Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. Clin. Chim. Acta 421 (2013), 181–183.
9. [9] Araki, M., Matsuoka, T., Miyamoto, K., Kusunoki, S., Okamoto, T., Murata, M., Miyake, S., Aranami, T., Yamamura, T., Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 82 (2014), 1302–1306.
10. [10] Takahashi, W., Nakada, T.A., Abe, R., Tanaka, K., Matsumura, Y., Oda, S., Usefulness of interleukin 6 levels in the cerebrospinal fluid for the diagnosis of bacterial meningitis. J. Crit. Care 29 (2014), 693.e1–693.e6.
11. [11] Kamei, S., Taira, N., Ishihara, M., Sekizawa, T., Morita, A., Miki, K., Shiota, H., Kanno, A., Suzuki, Y., Mizutani, T., Itoyama, Y., Morishima, T., Hirayanagi, K., Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine 46 (2009), 187–193.
12. [12] Ichiyama, T., Shoji, H., Takahashi, Y., Matsushige, T., Kajimoto, M., Inuzuka, T., Furukawa, S., Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis. Cytokine 44 (2008), 149–153.
13. [13] Dixit, P., Garg, R.K., Malhotra, H.S., Jain, A., Verma, R., Sharma, P.K., Kumar, N., Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis. Inflamm. Res. 65 (2016), 125–132.
14. [14] Ishizu, T., Minohara, M., Ichiyama, T., Kira, R., Tanaka, M., Osoegawa, M., Hara, T., Furukawa, S., Kira, J., CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J. Neuroimmunol. 175 (2006), 52–58.
15. [15] Peltola, J., Palmio, J., Korhonen, L., Suhonen, J., Miettinen, A., Hurme, M., Lindholm, D., Keränen, T., Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res. 41 (2000), 205–211.
16. [16] Beridze, M., Sanikidze, T., Shakarishvili, R., Intskirveli, N., Bornstein, N.M., Selected acute phase CSF factors in ischemic stroke: findings and prognostic value. BMC Neurol., 11, 2011, 41.
17. [17] Sasayama, T., Nakamizo, S., Nishihara, M., Kawamura, A., Tanaka, H., Mizukawa, K., Miyake, S., Taniguchi, M., Hosoda, K., Kohmura, E., Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL). Neuro-Oncology 14 (2012), 368–380.
18. [18] Polman, C.H., Reingold, S.C., Banwell, B., Clanet, M., Cohen, J.A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F.D., Montalban, X., O'Connor, P., Sandberg-Wollheim, M., Thompson, A.J., Waubant, E., Weinshenker, B., Wolinsky, J.S., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69 (2011), 292–302.
19. [19] Hayakawa, S., Mori, M., Okuta, A., Kamegawa, A., Fujiyoshi, Y., Yoshiyama, Y., Mitsuoka, K., Ishibashi, K., Sasaki, S., Hattori, T., Kuwabara, S., Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J. Neuroimmunol. 196 (2008), 181–187.
20. [20] Chihara, N., Aranami, T., Sato, W., Miyazaki, Y., Miyake, S., Okamoto, T., Ogawa, M., Toda, T., Yamamura, T., Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 3701–3706.
21. [21] Chihara, N., Aranami, T., Oki, S., Matsuoka, T., Nakamura, M., Kishida, H., Yokoyama, K., Kuroiwa, Y., Hattori, N., Okamoto, T., Murata, M., Toda, T., Miyake, S., Yamamura, T., Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica. PLoS One, 8, 2013, e83036.
22. [22] Lambertsen, K.L., Biber, K., Finsen, B., Inflammatory cytokines in experimental and human stroke. J. Cereb. Blood Flow Metab. 32 (2012), 1677–1698.
23. [23] Herrmann, O., Tarabin, V., Suzuki, S., Attigah, N., Coserea, I., Schneider, A., Vogel, J., Prinz, S., Schwab, S., Monyer, H., Brombacher, F., Schwaninger, M., Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J. Cereb. Blood Flow Metab. 23 (2003), 406–415.
24. [24] Yee, C., Biondi, A., Wang, X.H., Iscove, N.N., de Sousa, J., Aarden, L.A., Wong, G.G., Clark, S.C., Messner, H.A., Minden, M.D., A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 74 (1989), 798–804.
25. [25] Nishimoto, N., Yoshizaki, K., Eiraku, N., Machigashira, K., Tagoh, H., Ogata, A., Kuritani, T., Osame, M., Kishimoto, T., Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J. Neurol. Sci. 97 (1990), 183–193.
26. [26] Merbl, Y., Sommer, A., Chai, O., Aroch, I., Zimmerman, G., Friedman, A., Soreq, H., Shamir, M.H., Tumor necrosis factor-α and interleukin-6 concentrations in cerebrospinal fluid of dogs after seizures. J. Vet. Intern. Med. 28 (2014), 1775–1781.
27. [27] Sellebjerg, F., Bendtzen, K., Christiansen, M., Frederiksen, J., Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis. Eur. J. Neurol. 4 (1997), 59–67.
28. [28] Mei, F.J., Ishizu, T., Murai, H., Osoegawa, M., Minohara, M., Zhang, K.N., Kira, J., Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF. J. Neurol. Sci. 228 (2005), 75–85.
29. [29] García-Hernández, P., Prieto, B., Martínez-Morillo, E., Rodríguez, V., Álvarez, F.V., Interleukin-6 in cerebrospinal fluid as a biomarker of acute meningitis. Ann. Clin. Biochem. 53 (2016), 155–163.
30. [30] Miyazawa, I., Abe, T., Narikawa, K., Feng, J., Misu, T., Nakashima, I., Fujimori, J., Tamai, M., Fujihara, K., Itoyama, Y., Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. J. Neuroimmunol. 158 (2005), 240–244.
31. [31] Norose, K., Yano, A., Wang, X.C., Tokushima, T., Umihira, J., Seki, A., Nohara, M., Segawa, K., Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease. Invest. Ophthalmol. Vis. Sci. 35 (1994), 33–39.